Vaccines Clinical Trial
Official title:
Simple Blind, Placebo Controlled, Randomized Safety and Reactogenicity Trial of "Baby-Hib [Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b], Lyophilizate for Preparation of Intramuscular Injection Solution, 0.5 mL/Dose", FSUE SPbSRIVS FMBA of Russia, in Volunteers Aged 18-50
Trial purpose is to evaluate the safety, tolerability and reactogenicity of the Vaccine for the prevention of infections caused by Haemophilus Influenzae Type b in volunteers aged 18-50.
The trial includes 2 stages (Stage I and Stage II). The aim of the Stage I is to assess the tolerability, reactogenicity and safety of the Hib vaccine in the first 10 volunteers during the first 7 days after vaccination. The aim of the Stage I is to assess the tolerability, reactogenicity and safety of the Hib vaccine during 28 days after vaccination and also to conduct a comparative assessment of the safety and reactogenicity of the Hib vaccine and placebo during 28 days after vaccination. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01461980 -
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
|
Phase 2 | |
| Completed |
NCT01461993 -
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
|
Phase 2 | |
| Not yet recruiting |
NCT05993325 -
Immunogenicity and Safety of AdCLD-CoV19-1 OMI as a Booster: A COVID-19 Preventive Vaccine in Healthy Volunteers
|
Phase 3 | |
| Completed |
NCT02692976 -
Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT05284097 -
Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study
|
Phase 2 | |
| Recruiting |
NCT06259487 -
Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.
|
N/A | |
| Active, not recruiting |
NCT05576623 -
Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine
|
Phase 1/Phase 2 | |
| Completed |
NCT03294551 -
HPV Centralized R/R RCT #2 - New York State
|
N/A | |
| Completed |
NCT03666026 -
Patient Portal - Flu Reminder Recall
|
N/A | |
| Recruiting |
NCT05586204 -
Boost Intentions and Facilitate Action to Promote COVID-19 Booster Take-up
|
N/A | |
| Recruiting |
NCT05586165 -
Effects of Prompt to Bundle COVID-19 Booster and Flu Shot
|
N/A | |
| Recruiting |
NCT05586178 -
Information Provision and Consistency Framing to Increase COVID-19 Booster Uptake
|
N/A | |
| Completed |
NCT03294473 -
Centralized Reminder Recall - Flu RCT2
|
N/A | |
| Completed |
NCT05593042 -
Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chile
|
Phase 2 | |
| Completed |
NCT04651790 -
Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults
|
Phase 3 | |
| Completed |
NCT01697007 -
A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique
|
Phase 2 | |
| Completed |
NCT03548337 -
Study To Describe The Safety, Tolerability, And Immunogenicity Of 13- Valent Pneumococcal Conjugate Vaccine Formulated In Multidose Vials When Given With Routine Pediatric Vaccines In Healthy Infants In India
|
Phase 4 | |
| Completed |
NCT02609035 -
Immunization Services Model for Adult Rate Improvement
|
N/A | |
| Active, not recruiting |
NCT05032976 -
Korea Comirnaty Post-marketing Surveillance
|
||
| Completed |
NCT00340431 -
Experimental Vaccine for Plasmodium Falciparum Malaria
|
Phase 1 |